Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention to Enhance Cognitive Augmentation and Neuroplasticity (I-CAN)

NCT07609030 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT07609030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07609030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention to Enhance Cognitive Augmentation and Neuroplasticity (I-CAN)
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
April 28, 2026
Completion date
December 31, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent b-cell non-hodgkin lymphoma, recurrent multiple myeloma, refractory b-cell non-hodgkin lymphoma, refractory multiple myeloma